Cheol‐Hee Yoon

918 total citations
34 papers, 699 citations indexed

About

Cheol‐Hee Yoon is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Cheol‐Hee Yoon has authored 34 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 17 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in Cheol‐Hee Yoon's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (16 papers) and Immune Cell Function and Interaction (5 papers). Cheol‐Hee Yoon is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (16 papers) and Immune Cell Function and Interaction (5 papers). Cheol‐Hee Yoon collaborates with scholars based in South Korea, United States and Bangladesh. Cheol‐Hee Yoon's co-authors include Yong‐Soo Bae, Eun-Soo Lee, Yeon-Soo Kim, Byeong‐Sun Choi, M CHO, So‐Youn Min, Cheong‐Weon Cho, Young Lae Moon, Soo‐Jin Park and Sang‐Min Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Cheol‐Hee Yoon

33 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheol‐Hee Yoon South Korea 14 386 227 130 124 94 34 699
Manabu Taura Japan 20 420 1.1× 340 1.5× 250 1.9× 89 0.7× 141 1.5× 33 966
Concetta Pietropaolo Italy 17 498 1.3× 245 1.1× 93 0.7× 218 1.8× 86 0.9× 26 1.0k
Sonja Thaler Germany 14 274 0.7× 103 0.5× 162 1.2× 84 0.7× 49 0.5× 25 542
Line Saffar France 16 361 0.9× 226 1.0× 202 1.6× 102 0.8× 61 0.6× 30 839
Katherine Bao United States 9 325 0.8× 411 1.8× 115 0.9× 72 0.6× 48 0.5× 13 921
Laurent Chêne France 16 317 0.8× 264 1.2× 68 0.5× 234 1.9× 113 1.2× 24 780
Yongxin Mu China 19 480 1.2× 185 0.8× 102 0.8× 44 0.4× 235 2.5× 33 905
Lai Wang China 13 266 0.7× 130 0.6× 155 1.2× 62 0.5× 90 1.0× 36 675
Peter DeLong United States 14 203 0.5× 213 0.9× 247 1.9× 90 0.7× 55 0.6× 20 770
Ian Gaël Rodrigue‐Gervais Canada 11 571 1.5× 356 1.6× 104 0.8× 30 0.2× 199 2.1× 13 880

Countries citing papers authored by Cheol‐Hee Yoon

Since Specialization
Citations

This map shows the geographic impact of Cheol‐Hee Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐Hee Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐Hee Yoon more than expected).

Fields of papers citing papers by Cheol‐Hee Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheol‐Hee Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐Hee Yoon. The network helps show where Cheol‐Hee Yoon may publish in the future.

Co-authorship network of co-authors of Cheol‐Hee Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Cheol‐Hee Yoon. A scholar is included among the top collaborators of Cheol‐Hee Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheol‐Hee Yoon. Cheol‐Hee Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Dong‐Eun, et al.. (2025). ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation. PLoS ONE. 20(5). e0322962–e0322962.
2.
Kim, Dong‐Eun, et al.. (2023). A Novel Time-Resolved Fluorescence Resonance Energy Transfer Assay for the Discovery of Small-Molecule Inhibitors of HIV-1 Tat-Regulated Transcription. International Journal of Molecular Sciences. 24(11). 9139–9139. 4 indexed citations
3.
Choi, Yonghyun, Jiwon Kim, Cheol‐Hee Yoon, et al.. (2023). Nanosome‐Mediated Delivery Of Hdac Inhibitors and Oxygen Molecules for the Transcriptional Reactivation of Latent Hiv‐Infected Cd4+ T Cells. Small. 19(37). e2301730–e2301730. 8 indexed citations
4.
Yoon, Cheol‐Hee, Sin Young Choi, Jung‐Eun Kim, et al.. (2021). Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors. Infection and Chemotherapy. 53(3). 489–489. 5 indexed citations
5.
Lee, Hye Won, Yongwook Choi, Ah Ram Lee, et al.. (2021). Hepatocyte Growth Factor-Dependent Antiviral Activity of Activated cdc42-Associated Kinase 1 Against Hepatitis B Virus. Frontiers in Microbiology. 12. 800935–800935. 4 indexed citations
6.
Lee, Sun Young, Byeong‐Sun Choi, Cheol‐Hee Yoon, et al.. (2018). Selection of biomarkers for HIV-1 latency by integrated analysis. Genomics. 111(3). 327–333. 6 indexed citations
7.
Lim, Hoyong, Byeong‐Sun Choi, Kyung-Chang Kim, et al.. (2016). Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs. Virology Journal. 13(1). 141–141. 12 indexed citations
8.
Lim, Hoyong, et al.. (2016). Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor. Virus Research. 227. 1–5. 15 indexed citations
9.
Chung, Yoon‐Seok, et al.. (2015). Interferon-inducible protein 10 (IP-10) is associated with viremia of early HIV-1 infection in Korean patients. Journal of Medical Virology. 87(5). 782–789. 16 indexed citations
10.
Yoon, Cheol‐Hee, Hoyong Lim, Jihwan Park, et al.. (2015). Impaired IL-2 expression in latent HIV-1 infection. Biochemical and Biophysical Research Communications. 463(4). 1237–1242. 5 indexed citations
11.
Yoon, Cheol‐Hee, Sang‐Yoon Kim, Se Eun Byeon, et al.. (2015). p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation. Journal of Virology. 89(8). 4262–4280. 34 indexed citations
12.
Lee, Jinjoo, et al.. (2015). Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system. Vaccine. 33(38). 4827–4836. 2 indexed citations
13.
Woo, Hyun Ju, et al.. (2015). Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells. International Journal of Oncology. 46(6). 2656–2662. 15 indexed citations
14.
Kim, Hye‐Young, Byeong‐Sun Choi, Sung Soon Kim, et al.. (2014). NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter. Retrovirology. 11(1). 67–67. 21 indexed citations
15.
16.
17.
Lee, Eun-Soo, Cheol‐Hee Yoon, Yeon-Soo Kim, & Yong‐Soo Bae. (2007). The double‐strand RNA‐dependent protein kinase PKR plays a significant role in a sustained ER stress‐induced apoptosis. FEBS Letters. 581(22). 4325–4332. 95 indexed citations
18.
Kim, Duk‐Kyung, Che Ok Jeon, Kim Ys, et al.. (2006). Cytoplasmic transduction peptide (CTP): New approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Experimental Cell Research. 312(8). 1277–1288. 72 indexed citations
19.
CHO, M, Young Lae Moon, So‐Youn Min, et al.. (2005). Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunology Letters. 103(2). 159–166. 106 indexed citations
20.
Jeong, Jong‐Min, Byong‐Taek Lee, Cheol‐Hee Yoon, Hyungmin Kim, & Cheorl‐Ho Kim. (2004). Effects of on the proliferation of human bone cells and the immunomodulatory activity. Pharmacological Research. 51(2). 125–136. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Taura Breakdown of academic impact, for papers by Concetta Pietropaolo Breakdown of academic impact, for papers by Sonja Thaler Breakdown of academic impact, for papers by Line Saffar Breakdown of academic impact, for papers by Katherine Bao Breakdown of academic impact, for papers by Laurent Chêne Breakdown of academic impact, for papers by Yongxin Mu Breakdown of academic impact, for papers by Lai Wang Breakdown of academic impact, for papers by Peter DeLong Breakdown of academic impact, for papers by Ian Gaël Rodrigue‐Gervais
Rankless by CCL
2026